HOME >> BIOLOGY >> NEWS
Therapeutic cloning may be permitted at Newcastle University

A special licensing committee of the UK Human Fertilization & Embryology Authority (HFEA) met on June 16 in London to decide whether to grant a license to scientists at The Center for Life at Newcastle University. If approved, this will be the first license to begin research involving cell nuclear replacement (therapeutic cloning), focusing on the treatment of diabetes in the UK and will be a first in Europe.

Therapeutic cloning, for the derivation of embryonic stem cells, has the potential to lead to cures for serious diseases such as Alheizmer's, Parkinson's, heart failure and cancer. The UK has a strict regulatory system for human embryonic stem cell research. If the license is approved, it will allow this important work to begin. The UK was one of the first countries in the world to pass legislation to explicitly ban reproductive cloning.

Dr. Miodrag Stojkovic of Newcastle University who leads the research team said that he was very happy that the law in the UK allows scientists to work in this very promising field and use their knowledge in stem cell biology and nuclear transfer technique to bring faster and more efficient stem cells from the bench to the patient's bed.

Newcastle University's Institute of Human Genetics and the Life Fertility Center is one of only two groups in the UK to derive human ES (embryonic stem cells) from spare IVF embryos.

ES cells can be used to make any cell type in the body and replace cells that have been lost as a result of disease or injury. Cells derived from ES cells may often be genetically different from the patient, and transplanted cells could be rejected by the patient's immune system.

The Newcastle stem cell group will use nuclear transfer to derive stem cells that are genetically identical to those of a patient. In this case the stem cells and cells derived from them would not be rejected after being transplanted into a p
'"/>

Contact: Chris Pook
Chris.Pook@fco.gov.uk
202-588-6674
British Information Services
17-Jun-2004


Page: 1 2

Related biology news :

1. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
2. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
3. Therapeutic cloning no longer a dream, says scientist who produced first cloned embryonic stem cell
4. PTC Therapeutics researchers identify biochemical pathway important for modulating cell growth
5. Critical Therapeutics announces issuance of US patent for novel anti-inflammatory technology
6. Medimmune and Critical Therapeutics to co-develop treatments for severe inflammatory diseases
7. Immerge BioTherapeutics announces new findings addressing key safety risk in xenotransplantation
8. Critical Therapeutics launches Phase I clinical trial of anti-inflammatory compound
9. Immerge BioTherapeutics announces identification of PERV receptor
10. Hemocellular Therapeutics establishes licensing agreement with UNC, ECU
11. Dana-Farber launches NFCR Center for Therapeutic Antibody Research and Engineering

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/6/2019)... FRANCISCO (PRWEB) , ... February 04, 2019 , ... ... of a new Explorer™ story which provides insights to help individuals understand how ... to decreased cardiovascular wellness. , After individuals eat foods that contain choline ...
(Date:2/2/2019)... ... January 31, 2019 , ... ... providing full, customizable clinical research services across multiple therapeutic areas, announced an ... early stage life science entrepreneurs in the Research Triangle region of North ...
(Date:1/25/2019)... ... January 24, 2019 , ... ... its 2019 Association Industry Survey. The report indicates membership growth in some sectors ... to early December 2018, received responses from over 500 association professionals across North ...
Breaking Biology News(10 mins):
(Date:2/2/2019)... ... February 01, 2019 , ... Biomatlante, a world leader in ... CEO, Julien Dert, being effective on February 1st, 2019. , Graduated from ICN ... in which more than 12 years in the Medical Device industry. Chief Financial ...
(Date:1/30/2019)... ... January 29, 2019 , ... K&R Negotiations announced today that Mladen Kresic, CEO ... event titled: Six Ways to Shorten the Sales Cycle : Reduce Complexity and ... the BrightTALK network. , Negotiation expert Kresic will discuss the realities of today’s ...
(Date:1/28/2019)... (PRWEB) , ... January 28, 2019 , ... ... libraries of low molecular weight compounds. In this early stage, false positives can ... the same time, it is vital that screening techniques are highly sensitive to ...
(Date:1/21/2019)... ... January 21, 2019 , ... Microbial Discovery Group (MDG), ... industrial and institutional cleaning market. MDG’s SporActiv liquid and powder product line contains ... include odor control, floor and tile cleaners, carpets, drains, portable restroom cleaning and ...
Breaking Biology Technology:
Cached News: